Stock Analysis

Baird Medical Investment Holdings Reports First Half 2024 Earnings

NasdaqCM:BDMD
Source: Shutterstock

Baird Medical Investment Holdings (NASDAQ:BDMD) First Half 2024 Results

Key Financial Results

  • Net income: US$4.33m (up by US$4.33m from 1H 2023).
  • EPS: US$0.15.
earnings-and-revenue-history
NasdaqCM:BDMD Earnings and Revenue History October 12th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Baird Medical Investment Holdings shares are down 23% from a week ago.

Risk Analysis

It's necessary to consider the ever-present spectre of investment risk. We've identified 3 warning signs with Baird Medical Investment Holdings (at least 2 which are potentially serious), and understanding these should be part of your investment process.

Valuation is complex, but we're here to simplify it.

Discover if Baird Medical Investment Holdings might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.